Parkman Healthcare Partners’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.13M | Buy |
867,813
+272,826
| +46% | +$2.56M | 0.93% | 39 |
|
|
2025
Q1 | $7.31M | Buy |
594,987
+68,014
| +13% | +$836K | 0.87% | 41 |
|
|
2024
Q4 | $6.97M | Buy |
526,973
+18,690
| +4% | +$247K | 0.93% | 40 |
|
|
2024
Q3 | $9.78M | Sell |
508,283
-92,415
| -15% | -$1.78M | 1.25% | 28 |
|
|
2024
Q2 | $12.3M | Sell |
600,698
-184,113
| -23% | -$3.78M | 1.65% | 19 |
|
|
2024
Q1 | $18.7M | Buy |
784,811
+46,222
| +6% | +$1.1M | 2.29% | 10 |
|
|
2023
Q4 | $16M | Buy |
738,589
+526,141
| +248% | +$11.4M | 2.25% | 15 |
|
|
2023
Q3 | $3.08M | Buy |
212,448
+4,182
| +2% | +$60.7K | 0.57% | 50 |
|
|
2023
Q2 | $4.36M | Buy |
+208,266
| New | +$4.36M | 0.76% | 39 |
|
|
2021
Q1 | – | Sell |
-31,386
| Closed | -$698K | – | 95 |
|
|
2020
Q4 | $698K | Buy |
31,386
+1,381
| +5% | +$30.7K | 0.18% | 76 |
|
|
2020
Q3 | $443K | Buy |
30,005
+5
| +0% | +$74 | 0.12% | 83 |
|
|
2020
Q2 | $445K | Buy |
+30,000
| New | +$445K | 0.13% | 75 |
|